Home Must Reads Lake Oswego biotech company battles critics

Lake Oswego biotech company battles critics

| Print |  Email
Must Reads
Monday, December 03, 2012

Lake Oswego's Galena Biopharma is working toward a breast cancer vaccine, despite a negative online article that sent its stock from $1.98 to $1.40 in one day.

Galena's bouncy ride shows how the fragile existence of a small biotech firm rests on not just research and finance, but perception. And technology means conventional wisdom can change in a heartbeat.

Galena is fighting back, suing the suspected authors and reporting the matter to regulators as a case of stock manipulation.

Its lawsuit accuses the authors of printing falsehoods to wipe out $39 million of Galena's value. But in another sense, the suit aims at the growing role of the Internet in stock trading, where websites let anyone anonymously share analysis, rumors and even misinformation while readers -- and authors -- make money when prices fluctuate.

Read more at OregonLive.com.

{biztweet}galena{/biztweet}

 

More Articles

October surprise

News
Sunday, October 12, 2014
roundup-logo-thumb-14BY LINDA BAKER

Cylvia Hayes, tabloid vs. watchdog journalism and the looming threat of a Cascadia earthquake.


Read more...

Water World

November/December 2014
Wednesday, October 22, 2014
BY KIM MOORE

Fred Ziari aims to feed the global population.


Read more...

Healthcare Perspective

November/December 2014
Wednesday, October 22, 2014
BY KIM MOORE

A conversation with Majd El-Azma, president and CEO of LifeWise Health Plan of Oregon, followed by the Healthcare Powerlist.


Read more...

Innovation: a critique

News
Wednesday, October 08, 2014
1008 innovation thumbBY LINDA BAKER | OB EDITOR

A Design Week panel discussion raises questions about how innovative we really are.


Read more...

Gone Girl

News
Monday, September 29, 2014
roundup-logo-thumb-14BY LINDA BAKER | OB EDITOR

Wehby disappears, Kitzhaber fails to disclose and Seattle gets bike share before Portland.


Read more...

Healthcare pullback

News
Thursday, November 20, 2014
112014-boehnercare-thumbBY JASON NORRIS | OB CONTRIBUTOR

Each month for Oregon Business, we assess factors that are shaping current capital market activity—and what they mean to investors. Here we take a look at two major developments regarding possible rollbacks of the Affordable Care Act (ACA).


Read more...

Semiconductor purgatory

News
Monday, October 06, 2014
roundup-logo-thumb-14BY LINDA BAKER | OB EDITOR

Intel's manufacturing way station; Merkley's attack dog; Diamond Foods gets into the innovation business.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS